Exagen vs BZAM: Comparing Two Healthcare Companies in Laboratory Diagnostics

Hepatitis A is a viral infection that affects the liver and is caused by the hepatitis A virus (HAV). Unlike other forms of hepatitis, hepatitis A does not lead to chronic liver disease and is usually self-limiting, meaning it resolves on its own. The infection spreads primarily through contaminated food or water, or through direct contact with an infected person. Understanding how to diagnose hepatitis A through laboratory testing is essential for proper disease management and prevention of outbreaks.

Laboratory diagnosis of hepatitis A relies mainly on detecting specific antibodies in the blood. When someone is infected with hepatitis A, their immune system produces two types of antibodies: IgM and IgG. The IgM antibody appears early in the infection and indicates an acute or recent infection. This antibody can be detected in blood samples within a few days after symptoms appear and typically remains detectable for about three to six months. The presence of anti-HAV IgM is the primary marker used to confirm acute hepatitis A infection.

The IgG antibody develops later during the infection and persists for life, providing long-term immunity against future hepatitis A infections. Testing positive for anti-HAV IgG without the presence of IgM indicates past infection or vaccination, and confirms that the person has immunity to hepatitis A. This distinction between IgM and IgG antibodies is crucial for healthcare providers to determine whether a patient has an active infection requiring monitoring or simply has immunity from previous exposure or vaccination.

Additional laboratory tests may be performed to assess liver function and the extent of liver involvement. These include liver enzyme tests such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST), which become elevated during hepatitis A infection due to liver cell damage. Bilirubin levels may also be measured, as they often increase during the acute phase of the disease, causing jaundice. While these tests do not specifically diagnose hepatitis A, they help evaluate the severity of liver inflammation and monitor recovery.

Testing for hepatitis A is recommended for individuals showing symptoms of hepatitis such as fever, fatigue, loss of appetite, nausea, abdominal pain, dark urine, or jaundice. It is also important for people who have been exposed to someone with hepatitis A, travelers to areas where the disease is common, and during outbreak investigations. Early and accurate laboratory diagnosis helps in implementing appropriate patient care, preventing transmission to others, and initiating public health measures when necessary.